DarioHealth Corp. Insider Trading

DRIO

⊜ Compare

Last 12 months

Insiders bought 100K on the open market and sold nothing.

Net open-market

+100K

1 buy · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Jul 2026

Jul 23, 2026

Get an email when DRIO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jul 23	Dennis Matheis Director	Bought	14,430	$6.93	100K	50%	Form 4
Aug 27, 2025	Steven Charles Nelson President and CCO	Bought	40,000	$0.53	21K	73%	Form 4
Nov 12, 2024	Steven Charles Nelson Chief Commercial Officer	Bought	5,000	$0.91	5K	10%	Form 4

Jul 23
Dennis Matheis
Director · bought 14,430 at $6.93
100K
50% of stake
Aug 27, 2025
Steven Charles Nelson
President and CCO · bought 40,000 at $0.53
21K
73% of stake
Nov 12, 2024
Steven Charles Nelson
Chief Commercial Officer · bought 5,000 at $0.91
5K
10% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DRIO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with DRIO

CompareIntrinsic value

NEPHNephros Inc.

$3.25+0.31%54

VVOSVivos Therapeutics, Inc.

$0.11+0.91%26

SNOASonoma Pharmaceuticals Inc.

$1.11-2.63%40

SRTSSensus Healthcare Inc.

$3.25-1.07%18

PROFProfound Medical Corp.

$7.16+2.43%50

MDAISpectral AI Inc.

$1.53+2.00%10

BTCYBiotricity Inc.

$0.06+1.29%64

DYNTQDynatronics Corp

$0.00+0.00%29

Spot a number that looks wrong? Check it in DRIO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DRIO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.